Unterschiedliche Virustransmission und klinischer Verlauf einer Zytomegalievirus-Infektion bei dichorialer Geminigravidität

Die pränatale Infektion mit dem humanen Zytomegalievirus (HCMV) ist die häufigste Ursache für nicht genetisch bedingte Fehlbildungen und Entwicklungsstörungen (v. a. Taubheit und psychomotorische Retardierung). Die CMV-Infektion kann auch zu Frühgeburtlichkeit und intrauterinem Fruchttod führen [1] [2]. Eine ungleichmäßige Virustransmission und der unterschiedliche klinische Verlauf wurden bei Zwillingsschwangerschaften bisher nur in Einzelfällen beschrieben. Im Folgenden wird ein solcher Fall vorgestellt.

Publikationsverlauf

Artikel online veröffentlicht:
03. Januar 2024

• Literatur

• 1 Picone O, Vauloup-Fellous C, Cordier AG. et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 2013; 33: 751-758
• 2 Pass RF, Fowler KB, Boppana SB. et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006; 35: 216-220
• 3 Enders G, Daiminger A, Bäder U. et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 2011; 52: 244-246
• 4 Revello MG, Zavattoni M, Furione M. et al. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002; 186: 553-557
• 5 Leruez-Ville M, Ville Y. Fetal cytomegalovirus infection. Best Pract Res Clin Obstet Gynaecol 2017; 38: 97-107
• 6 Voigt S, Schaffrath Rosario A, Mankertz A. Cytomegalovirus seroprevalence among children and adolescents in Germany: data from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003–2006. Open Forum Infect Dis 2016; 3: ofv193
• 7 Leruez-Ville M, Stirnemann J, Sellier Y. et al. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis. Am J Obstet Gynecol 2016; 215: 342.e1-342.e9
• 8 Benoist G, Salomon LJ, Jacquemard F. et al. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG 2008; 115: 823-829
• 9 Guerra B, Simonazzi G, Puccetti C. et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008; 198: 380.e1-380.e7
• 10 Enders M, Daiminger A, Exler S. et al. Prenatal diagnosis of congenital cytomegalovirus infection in 115 cases: a 5 years’ single center experience. Prenat Diagn 2017; 198: 380
• 11 AWMF. S2k-Leitlinie Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. AWMF-Registriernummer 093/001. Gültig bis: 20.10.2026. Zugriff am 21. Oktober 2021 unter: https://register.awmf.org/de/leitlinien/detail/093–001
• 12 Akolekar R, Beta J, Picciarelli G. et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 16-26
• 13 Enders M, Daiminger A, Exler S. et al. Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks’ threshold. Prenat Diagn 2017; 37: 940-942
• 14 Faure-Bardon V, Fourgeaud J, Guilleminot T. et al. First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS. Ultrasound Obstet Gynecol 2021; 57: 568-572
• 15 Kagan KO, Enders M, Schampera MS. et al. Prevention of maternal-fetal transmission of CMV by hyperimmunoglobulin administered after a primary maternal CMV infection in early gestation. Ultrasound Obstet Gynecol 2019; 53: 383-389
• 16 Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304: 859-866
• 17 Leruez-Ville M, Ghout I, Bussières L. et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol 2016; 215: 462.e1-462.e10
• 18 Jacquemard F, Yamamoto M, Costa JM. et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007; 114: 1113-1121
• 19 Hamprecht K, Goelz R. Postnatal cytomegalovirus infection through human milk in preterm infants: transmission, clinical presentation, and prevention. Clin Perinatol 2017; 44: 121-130
• 20 Yinon Y, Yagel S, Tepperberg-Dikawa M. et al. Prenatal diagnosis and outcome of congenital cytomegalovirus infection in twin pregnancies. BJOG 2006; 113: 295-300
• 21 Simioni C, Sanchez Oliveira Rde C, Moscovi T. et al. Twin pregnancy and congenital cytomegalovirus: case report and review. J Matern Fetal Neonatal Med 2013; 26: 622-624
• 22 Feng S, Liu P, Yang P. et al. Differential congenital cytomegalovirus infection in dichorionic diamniotic twins – A case report and literature review. IDCases 2022; 27: e01373